AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT02628366 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Personalized Dialysate Temperature
Description: Dialysis centres randomized to the intervention will provide temperature-reduced personalized hemodialysis. A nurse will set the temperature of the dialysate to 0.5°C below each patient's body temperature measured just before starting the dialysis treatment. We are aware that some dialysis machines (e.g. Fresenius 5008) are only able to modify dialysate temperature by 0.5°C increments. For centres with those machines, the nurse will set the dialysate temperature 0.5 to 0.9 °C below each patient's body temperature (measured before starting the hemodialysis treatment) to a minimum of 35.5°C.
Study NCT01370772 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Rituximab
Description: * Cycle 1 Rituximab : 375 mg/m² i.v on day 1~* Cycle 2-6 Rituximab:500 mg/m² i.v on day 1, repeated every 28 days
Study NCT01370772 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rituximab
Description: * Prephase: Rituximab:500 mg on day 0, 2000 mg on days 1, 8, and D15~* Cycle 1-6 cycle 1 beginning at D22: Rituximab: 500 mg/m2 i.v on day 1, repeated every 28 days
Study NCT01370772 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Description: •FCR Cycle 1-6: Cyclophosphamide : 250 mg/m² per os, days 2-4, repeated every 28 days
Study NCT01370772 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Cyclophosphamide
Description: •FCR Cycle 1-6: Cyclophosphamide : 250 mg/m² per os, days 2-4, repeated every 28 days
Study NCT01370772 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fludarabine
Description: FCR Cycle 1-6: Fludarabine :40 mg/m² per os, days 2-4, repeated every 28 days
Study NCT01370772 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Fludarabine
Description: FCR Cycle 1-6: Fludarabine :40 mg/m² per os, days 2-4, repeated every 28 days
Study NCT02639754 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Social Network Leader Endorsement
Description: Leaders of social networks will attend a multi-session intervention during which they will be trained to deliver messages endorsing frequent HIV testing, compliance with medical guidelines, and adherence to medical treatment regimens to friends. Additionally, these leaders will be trained on how to deliver effective messages.
Study NCT02639754 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: HIV Counseling
Description: At the baseline session, participants in this condition will receive counseling about the benefits and availability of HIV care and the importance of frequent HIV testing.
Study NCT02332694 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: The Whole Body Hyperthermia system uses water-filtered infrared-A (wIRA) heat radiation
Description: The Whole Body Hyperthermia system uses water-filtered infrared-A (wIRA) heat radiation. The rise in the body's core temperature is correspondingly rapid and well-tolerated. There are two phases of the thermal challenge, 1) Irradiation phase during which the patient lies recumbent with his/her head positioned outside the tent. The wIRA irradiators are arranged above the exposed upper part of the body; and 2) Heat retention phase during which the patient lies in the chamber with the walls of the tent positioned to retain heat. Core body temperatures will be raised to those comparable to a mild fever 37.8-38.5°C.
Study NCT00683774 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: diazoxide
Description: 100mg orally three times per day for 10 days
Study NCT00683774 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: diazoxide
Description: 100mg orally three times per day for 10 days
Study NCT01487928 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Human Milk Cream
Description: If the caloric level of human milk (mother's own or donor) falls below 20 kcal/oz, then an appropriate amount of human milk cream will be added to the milk to bring the content as close as possible to 20 kcal/oz. For example, if the human milk is 19 kcal/oz, 2 mL of human milk cream will be added to 100mL of human milk.
Study NCT01646346 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: 4D Conformal Image-Guided Partial Breast RT
Description: External beam partial breast radiation to target a portion of the breast twice a day for 5 days.
Study NCT03731910 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: MRI
Description: liver MRI using standard dose of extracellular agent. It includes dynamic contrast-enhanced MRI and diffusion weighted image.
Study NCT04496388 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: exercise
Description: different type of exercise
Study NCT02562053 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Placebo 1
Description: Women will receive oral placebo similar to COC daily for 21 days starting from the 3rd day of menstruation
Study NCT02562053 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo 1
Description: Women will receive oral placebo similar to COC daily for 21 days starting from the 3rd day of menstruation
Study NCT02562053 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo 2
Description: Women will receive a daily oral placebo similar to fluoxetine
Study NCT04203238 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Reduced Meat High Potato Diet
Description: The main entrée in the PLM arm will consist of a menu item in which 40% of the meat in the original recipe will be replaced with potatoes.
Study NCT04203238 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Reduced Meat High Pulses Diet
Description: The main entrée in the LMP arm will consist of a menu item in which 40% of the meat in the original recipe will be replaced with pulses.
Study NCT02792608 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mindfulness-based Therapy
Description: MBT will be delivered in group format, 135 minutes per week, for 5 consecutive weeks with 10-20 participants per group.
Study NCT04448288 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Static stretching
Description: Static stretchings were performed by subjects that involved varied repetitions of 30-s static-stretches and 20-s relax period.
Study NCT04496388 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: No exercise intervention
Description: No exercise intervention
Study NCT02631668 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ferrous succinate and vitamin C
Description: As experimental group, when patients take the tablets of ferrous succinate, they also take vitamin C at the same time
Study NCT02631668 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: ferrous succinate
Description: As active comparator, patients take the tablets of ferrous succinate with normal dosage in clinical practice
Study NCT03323931 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: (2) robot--enhanced intervention
Description: The tasks included in the treatment follow a structured behavioral approach, called the discrete trial training (DTT). The learning process is guided by the robotic agent (Softbank Robotics Nao robot). All activities follow a gameplay scenario and they take place at a table, which in the case of joint attention and turn taking tasks incorporates a large touchscreen. Each behavior presented to the child is preceded by instructions and followed by a contingent reinforcement. The contingent reinforcement and prompting are used to train each targeted behavior/action. The behaviors are presented over multiple and successive trials and explicit prompting is giving when the child doesn't succeed to accomplish the targeted behavior. Each action is repeated three times. For every child, the intervention for each ability starts from the level determined in the first two sessions, but as the child's performance improves, the task moves to a more complex level.
Study NCT03323931 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: (1) discrete trial training / cognitive-behavior therapy
Description: The tasks included in the treatment follow a structured behavioral approach, called the discrete trial training (DTT). The learning process is guided by an interaction partner (human), under the supervision of the therapist. All activities follow a gameplay scenario and they take place at a table, which in the case of joint attention and turn taking tasks incorporates a large touchscreen. Each behavior presented to the child is preceded by instructions and followed by a contingent reinforcement. The contingent reinforcement and prompting are used to train each targeted behavior/action. The behaviors are presented over multiple and successive trials and explicit prompting is giving when the child doesn't succeed to accomplish the targeted behavior. Each action is repeated three times. For every child, the intervention for each ability starts from the level determined in the first two sessions, but as the child's performance improves, the task moves to a more complex level.
Study NCT02631668 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: ferrous succinate
Description: As another active comparator, patients take the tablets of ferrous succinate with double dosage
Study NCT04023175 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Telemedicine preoperative counseling
Description: The telemedicine visit will be completed using an Atrium Health approved virtual visit platform.
Study NCT04023175 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: In office preoperative counseling
Description: This includes our standard preoperative counseling located at the Women's Center for Pelvic Health
Study NCT01697891 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Codetron ALTENS
Description: ALTENS stimulation of a set of selected acupuncture points for 20 minutes in each treatment. Two treatments per week for a total of 12 treatments to be delivered within 8 weeks.
Study NCT00756574 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Surgical mask
Description: Surgical mask worn for patients with febrile respiratory illness
Study NCT02692976 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: mDC vaccination
Description: Intranodal mDC vaccination
Study NCT02692976 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: pDC vaccination
Description: Intranodal pDC vaccination
Study NCT02692976 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: mDC and pDC vaccination
Description: Intranodal mDC/pDC vaccination
Study NCT00756574 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: N95 mask
Description: N95 mask worn for patients with febrile respiratory illness
Study NCT04012762 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Whole body vibration training
Description: Intermittent whole-body vibration exposure is a training method providing physical stimulation effect on skeletal muscles by increasing gravitational acceleration on the vibration platform.
Study NCT03626844 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Manual Lysis of Placenta after 15 minutes (Intervention)
Description: Manual Lysis of Placenta after 15 minutes: We administer prophylactic antibiotics, under epidural analgesia, under aseptic conditions, we perform manual lysis of placenta by introducing the hand through the vagina to the uterine cavity, separating and removing the placenta.
Study NCT03626844 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Manual Lysis of Placenta after 30 minutes (Control)
Description: Manual Lysis of Placenta after 30 minutes: We administer prophylactic antibiotics, under epidural analgesia, under aseptic conditions, we perform manual lysis of placenta by introducing the hand through the vagina to the uterine cavity, separating and removing the placenta.
Study NCT05617248 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Self-efficacy App
Description: The training starts with a psychoeducational video and instructions to define two autobiographical self-efficacy The individuals will then receive three self-efficacy trainings per day based on their autobiographical memories and combined with a slow breathing exercise. Additionally, they will receive 10 daily EMA questionnaires on mood, social contacts, and virtual context.
Study NCT03697863 — intervention group
Intervention type: PROCEDURE
Intervention: Noninvasive Respiratory Support
Description: Noninvasive Respiratory Support delivered by conventional flow triggered ventilation or neurally triggered ventilatory assist
Study NCT00700297 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Colchicine
Description: 100 mg Colchicine per day for 4 months
Study NCT00700297 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: One tablet placebo per day for 4 months
Study NCT04569864 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Hypothermic circulatory arrest with unilateral selective anterograde cerebral perfusion
Description: Hypothermic circulatory arrest provides protection to cerebral and visceral organs.
Study NCT04569864 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Hypothermic circulatory arrest with unilateral selective anterograde cerebral perfusion
Description: Hypothermic circulatory arrest provides protection to cerebral and visceral organs.
Study NCT02723916 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: ezParent Program
Description: Tablet-based behavioral parent training program.
Study NCT02723916 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Health-e Kids Control App
Description: Tablet based health promotion information App
Study NCT02835313 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: FAST alone
Description: Subjects participate in fast walking training 3x/week for 12 weeks.
Study NCT02835313 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: FAST+SAM
Description: Subjects participate in fast walking training plus a step activity monitoring program 3x/week for 12 weeks
Study NCT02835313 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: SAM alone
Description: Subjects participate in a step activity monitoring program 3x/week for 12 weeks
Study NCT00394043 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Osteopathic Manipulative Treatment
Description: A protocol of specific Osteopathic manipulative techniques was used.
Study NCT00394043 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Sub-Therapeutic Ultrasound
Description: Sub-therapeutic ultrasound was applied in a standardized method.
Study NCT02077829 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Illness Management and Recovery
Description: Evidence-based practice given individually or in groups, weekly for 10-12 months.
Study NCT02048137 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Transcranial direct current stimulation
Study NCT02048137 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Transcranial direct current stimulation
Study NCT02110680 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Sports TENS 2
Description: transcutaneous electric stimulation
Study NCT02110680 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sports TENS 2
Description: transcutaneous electric stimulation
Study NCT01891617 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise and diets
Description: Exercise and high-fat diet Exercise and high-carbohydrate diet Sedentary and high-fat diet Sedentary and high-carbohydrate diet
Study NCT02632669 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Hemigland focal LDR brachytherapy
Description: The treatment is limited to the hemigland that has been diagnosed with unilateral low to intermediate risk prostate cancer by means of pre-treatment staging with mpMRI and transperineal template biopsy. The affected hemigland will be treated with iodine-125 to a prescription dose of 145Gy. Patients will be assessed at baseline and subsequently at 6 weeks, 3, 6, 9, 12,18, 24 months after treatment with PSA and EN2 measurements and validated questionnaires relating to erectile, urinary, and bowel function and general health related quality of life. mpMRI and transperineal template biopsy will be performed 24 months after treatment.
Study NCT02950155 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rituximab
Description: A single infusion at a dose of 500 mg Mabthera/Rituximab.
Study NCT02950155 — intervention group
Intervention type: DRUG
Group type: SHAM_COMPARATOR
Intervention: Sodium Chloride solution
Description: A single infusion of Placebo/Sham.
Study NCT03523416 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcatheter Atrial Shunt System
Description: Transcatheter treatment of symptomatic left heart failure patients
Study NCT02591472 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Integrated care (ICare)
Description: The Integrated Care approach provides Usual Care processes plus simultaneous psychosocial support via the Transform-10 Program. The Transform-10 Program will include information regarding emotional well-being, social support, and provides opportunity for the patient to openly discuss their thoughts and concerns regarding their recovery. The patient's normal clinical care usually includes a hospital stay, a 2 week follow up, 6 week follow up, 12 week follow up, 6 month, and 1 year follow up visit.
Study NCT02591472 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Usual Care (UsCare)
Description: Usual Care includes radiographic imaging and administration of pain medication and antibiotics, skin care and range of motion of the injured area. The patient's normal clinical care usually includes a hospital stay, a 2 week follow up, 6 week follow up, 12 week follow up, 6 month, and 1 year follow up visit. At the end of the study all of the materials that make up the Transform-10 Program will be provided.
Study NCT02591472 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Patient-Reported Outcomes Measurement Information System
Description: Questionnaires of Physical Functional quality of life and Emotional Well-being will be performed during the hospital stay, a 2 week follow up, 6 week follow up, 12 week follow up, 6 month, and 1 year follow up visit.
Study NCT02591472 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Patient-Reported Outcomes Measurement Information System
Description: Questionnaires of Physical Functional quality of life and Emotional Well-being will be performed during the hospital stay, a 2 week follow up, 6 week follow up, 12 week follow up, 6 month, and 1 year follow up visit.
Study NCT02591472 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Lower Extremity Gain Scale (LEGS)
Description: LEGS consists of a 3-meter walk, putting on a sock, putting on a shoe, rising from an armless chair, stepping up and down stairs, getting on and off the toilet, reaching from a sitting position to an object on the ground. In people with traumatic fractures, LEGS has high internal consistency and the content, concurrent and construct validity are high. This assessment will be performed during the hospital stay, at the 2 week follow up, 6 week follow up, 12 week follow up, 6 month, and 1 year follow up visit.
Study NCT02591472 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Lower Extremity Gain Scale (LEGS)
Description: LEGS consists of a 3-meter walk, putting on a sock, putting on a shoe, rising from an armless chair, stepping up and down stairs, getting on and off the toilet, reaching from a sitting position to an object on the ground. In people with traumatic fractures, LEGS has high internal consistency and the content, concurrent and construct validity are high. This assessment will be performed during the hospital stay, at the 2 week follow up, 6 week follow up, 12 week follow up, 6 month, and 1 year follow up visit.
Study NCT02591472 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dynamometer
Description: Isometric handgrip strength will be measured using a hand-held hydraulic dynamometer. Handgrip strength is clinically important as it strongly predicts long-term function capability after orthopedic trauma. This assessment will be performed during the hospital stay, at the 2 week follow up, 6 week follow up, 12 week follow up, 6 month, and 1 year follow up visit.
Study NCT02591472 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Dynamometer
Description: Isometric handgrip strength will be measured using a hand-held hydraulic dynamometer. Handgrip strength is clinically important as it strongly predicts long-term function capability after orthopedic trauma. This assessment will be performed during the hospital stay, at the 2 week follow up, 6 week follow up, 12 week follow up, 6 month, and 1 year follow up visit.
Study NCT02591472 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Active Range of Motion (AROM)
Description: The use of goniometer and a digital inclinometer will be used to assess AROM. This assessment will be performed during the hospital stay, at the 2 week follow up, 6 week follow up, 12 week follow up, 6 month, and 1 year follow up visit.
Study NCT02591472 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Active Range of Motion (AROM)
Description: The use of goniometer and a digital inclinometer will be used to assess AROM. This assessment will be performed during the hospital stay, at the 2 week follow up, 6 week follow up, 12 week follow up, 6 month, and 1 year follow up visit.
Study NCT02591472 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Posttraumatic Stress Disorder (PTSD)
Description: The Posttraumatic Stress Disorder (PTSD) Checklist will be administered to measure posttraumatic stress levels. This assessment will be performed during the hospital stay, at the 2 week follow up, 6 week follow up, 12 week follow up, 6 month, and 1 year follow up visit.